BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28067877)

  • 1. Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.
    Fujiwara H; Fuji S; Wake A; Kato K; Takatsuka Y; Fukuda T; Taguchi J; Uchida N; Miyamoto T; Hidaka M; Miyazaki Y; Tomoyose T; Onizuka M; Takanashi M; Ichinohe T; Atsuta Y; Utsunomiya A;
    Bone Marrow Transplant; 2017 Mar; 52(3):484-488. PubMed ID: 28067877
    [No Abstract]   [Full Text] [Related]  

  • 2. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
    Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.
    Fuji S; Utsunomiya A; Inoue Y; Miyagi T; Owatari S; Sawayama Y; Moriuchi Y; Choi I; Shindo T; Yoshida SI; Yamasaki S; Yamaguchi T; Fukuda T
    Haematologica; 2018 May; 103(5):e211-e214. PubMed ID: 29371324
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment and survival among 1594 patients with ATL.
    Katsuya H; Ishitsuka K; Utsunomiya A; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Amano M; Hino R; Shimokawa M; Kawai K; Suzumiya J; Tamura K;
    Blood; 2015 Dec; 126(24):2570-7. PubMed ID: 26361794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
    Sawayama Y; Itonaga H; Fukushima T; Nakano N; Fujiwara H; Utsunomiya A; Fukuda T; Miyamoto T; Eto T; Miyashita K; Nakamae H; Ogata M; Yamanoha A; Miyazaki Y; Kanda J; Atsuta Y; Kato K;
    Am J Hematol; 2019 May; 94(5):E143-E146. PubMed ID: 30773707
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.
    Itonaga H; Sawayama Y; Taguchi J; Honda S; Taniguchi H; Makiyama J; Matsuo E; Sato S; Ando K; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Fukushima T; Miyazaki Y
    Bone Marrow Transplant; 2015 Apr; 50(4):585-91. PubMed ID: 25621801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.
    Fuji S; Yamaguchi T; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Owatari S; Miyagi T; Taguchi J; Choi I; Otsuka E; Nakachi S; Yamamoto H; Kurosawa S; Tobinai K; Fukuda T
    Haematologica; 2017 Jul; 102(7):1258-1265. PubMed ID: 28341734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma.
    Fukushima T; Miyazaki Y; Honda S; Kawano F; Moriuchi Y; Masuda M; Tanosaki R; Utsunomiya A; Uike N; Yoshida S; Okamura J; Tomonaga M
    Leukemia; 2005 May; 19(5):829-34. PubMed ID: 15744352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Fuji S; Kurosawa S; Inamoto Y; Murata T; Utsunomiya A; Uchimaru K; Yamasaki S; Inoue Y; Moriuchi Y; Choi I; Ogata M; Hidaka M; Yamaguchi T; Fukuda T
    Bone Marrow Transplant; 2018 Jul; 53(7):905-908. PubMed ID: 29371687
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
    Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.
    Ishida T; Jo T; Takemoto S; Suzushima H; Suehiro Y; Choi I; Yoshimitsu M; Saburi Y; Nosaka K; Utsunomiya A; Kobayashi Y; Yamamoto K; Fujiwara H; Ishitsuka K; Yoshida S; Taira N; Imada K; Kato K; Moriuchi Y; Yoshimura K; Takahashi T; Tobinai K; Ueda R
    Br J Haematol; 2019 Feb; 184(3):479-483. PubMed ID: 29411857
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey.
    Kato K; Choi I; Wake A; Uike N; Taniguchi S; Moriuchi Y; Miyazaki Y; Nakamae H; Oku E; Murata M; Eto T; Akashi K; Sakamaki H; Kato K; Suzuki R; Yamanaka T; Utsunomiya A
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):1968-74. PubMed ID: 25172635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pretransplant central nervous system invasion in patients with aggressive adult T-cell leukemia lymphoma.
    Fuji S; Inoue Y; Utsunomiya A; Moriuchi Y; Choi I; Otsuka E; Henzan H; Kato K; Nakachi S; Yamamoto H; Fukuda T
    Bone Marrow Transplant; 2019 Jan; 54(1):134-137. PubMed ID: 29899570
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
    Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
    Fuji S; Fujiwara H; Nakano N; Wake A; Inoue Y; Fukuda T; Hidaka M; Moriuchi Y; Miyamoto T; Uike N; Taguchi J; Eto T; Tomoyose T; Kondo T; Yamanoha A; Ichinohe T; Atsuta Y; Utsunomiya A;
    Bone Marrow Transplant; 2016 Feb; 51(2):205-11. PubMed ID: 26524263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?
    Phillips AA
    Leuk Lymphoma; 2017 Jan; 58(1):1-3. PubMed ID: 27786571
    [No Abstract]   [Full Text] [Related]  

  • 17. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.
    Zell M; Assal A; Derman O; Kornblum N; Battini R; Wang Y; Narasimhulu DM; Mantzaris I; Shastri A; Verma A; Ye H; Braunschweig I; Janakiram M
    Oncotarget; 2016 Aug; 7(32):51981-51990. PubMed ID: 27341021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcome of patients with relapsed/refractory adult T-cell leukemia-lymphoma after salvage therapy].
    Taniguchi H; Imaizumi Y; Makiyama J; Itonaga H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Tsushima H; Hata T; Hasegawa H; Hayashi T; Niino D; Ohshima K; Tsukasaki K; Miyazaki Y
    Rinsho Ketsueki; 2013 Dec; 54(12):2159-66. PubMed ID: 24452146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration.
    Hosoi H; Mushino T; Nishikawa A; Hashimoto H; Murata S; Hatanaka K; Tamura S; Hanaoka N; Shimizu N; Sonoki T
    Int J Hematol; 2018 Jun; 107(6):717-719. PubMed ID: 29671245
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adult T cell leukemia/lymphoma (ATL)].
    Tanosaki R
    Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.